öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÓÚÏþ»Ô
ÐÔ±ð£º
ÈËÆøÖ¸Êý£º48

ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧ
ËùÊôԺϵ£º
Ö°³Æ£º
µ¼Ê¦ÀàÐÍ£º
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º¸¾²ú¿Æѧ
Ñо¿ÁìÓò£º ¸¾¿ÆÖ×ÁöµÄ»ù´¡¼°ÁÙ´²Ñо¿£»×Ó¹¬ÄÚĤÒìλ֢µÄ»ù´¡¼°ÁÙ´²Ñо¿£»¸¾¿ÆÃÚÄòѧµÄ»ù´¡¼°ÁÙ´²Ñо¿
Ñо¿ÁìÓò£º ¸¾¿ÆÖ×ÁöµÄ»ù´¡¼°ÁÙ´²Ñо¿£»×Ó¹¬ÄÚĤÒìλ֢µÄ»ù´¡¼°ÁÙ´²Ñо¿£»¸¾¿ÆÃÚÄòѧµÄ»ù´¡¼°ÁÙ´²Ñо¿ [ÊÕÆð]




ͨѶ·½Ê½ :
°ì¹«µç»°£º**
µç×ÓÓʼþ£ºYuxiaohui369@163.com


¸öÈ˼òÊö :
ÓÚÏþ»Ô ÉϺ£½»Í¨´óѧҽѧԺ¸¾¿ÆÖ×Áöѧ²©Ê¿£¬Ö÷ÈÎҽʦ£¬Ä¿Ç°ÈδóÁ¬Êи¾Ó×±£½¡Ôº¸¾Å®Ò½ÁƱ£½¡ÖÐÐĸ±Ö÷ÈΣ¬¸¾¿ÆÖ÷ÈΣ¬´óÁ¬Ò½¿Æ´óѧ˶ʿÑо¿Éúµ¼Ê¦¡£¾«Í¨Ó¢ÓïºÍÈÕÓï¡£25ÄêÀ´ÔÚ³öÉ«Íê³É¸¾¿ÆÖ×ÁöÁÙ´²¹¤×÷ͬʱ£¬Ò²Ò»Ö±´Óʸ¾¿ÆÖ×ÁöµÈÏà¹ØÁÙ´²¿ÎÌâµÄÑо¿£¬²ÎÓë¼°Íê³ÉÁ˹ú¼Ò×ÔÈ»¿Æѧ»ù½ð¡¢½ÌÓý²¿ÖصãÏîÄ¿»ù½ðÒÔ¼°¶àÏîÊм¶¿ÎÌâÏîÄ¿µÄÑо¿¹¤×÷£¬ÆäÖйØÓÚÂѳ²°©µÄ¸ßתÒƺͻ¯ÁÆÄÍÒ©»úÖƵÄÑо¿ÒѾ­ÔÚ¹úÄÚÍâÖøÃûÆÚ¿¯·¢±íÂÛÎÄ20Óàƪ£»ÆäÖÐÂÛÎÄ¡¶Suppression of anoikis by the neurotrophic receptor TrkB in human ovarian cancer¡·SCIËûÒý´ÎÊýÒÑ´ï69´Î¡£»ñµÃ2008Äê´óÁ¬ÊС°ÍõÁÁʽ֪ʶÐÍÖ°¹¤¡±µÄ¹âÈٳƺÅ¡£»ñµÃ2011Äê¡°°ÙÐÕ×îϲ°®µÄÇàÄêÒ½Éú¡±ÌáÃû½±¡£É󤸾¿Æ¶ñÐÔ¼°Á¼ÐÔÖ×ÁöµÄÊÖÊõÖÎÁÆ£¬ÓÈÆäÊǸ¹Ç»¾µÏÂ×Ó¹¬¾±°©¡¢×Ó¹¬ÄÚĤ°©¼°ÔçÆÚÂѳ²°©µÄÊÖÊõÖÎÁÆÒÔ¼°ÅèÇ»Æ÷¹ÙÍÑ´¹µÄ΢´´ÊÖÊõÖÎÁÆ¡£

¿ÆÑй¤×÷ :
ÔÚÑпÎÌ⣺
2016ÄêÁÉÄþÊ¡×ÔÈ»¿Æѧ»ù½ðÏîÄ¿£º»ùÓÚ΢Á÷¿ØоƬµÄ´Æ¼¤ËØ΢»·¾³µ÷¿Ø×Ó¹¬ÄÚĤÒìλ֢»úÖÆÑо¿
´ú±íÐÔÎÄÕ£º
(1)Yu X*, Ren H, Liu T, Yong M, Zhong H. Expression and significance of ER¦Â and TrkB in endometriosis. Clin Exp Obstet Gynecol.201643(1):75-81. (IF:0.424)
(2)ÓºÃôæ¼ ÀîÎÄÙ» Íõ·¼ ½ðΰ Áõ²¨ ÓÚÏþ»Ô* ERsÓëTrkBÔÚ×Ó¹¬ÄÚĤÒìλ֢»¼Õß²»Í¬×Ó¹¬ÄÚĤ×éÖ¯Öеıí´ï¡£¹ú¼Ê¸¾²ú¿ÆѧÔÓÖ¾,2015,42(5):157-159
(3)ÓºÃô½Ü ÓÚÏþ»Ô* É½þÈóÐÍ×Ó¹¬ÄÚĤÒìλ֢Ñо¿½øÕ¹£¬ÊµÓÃҽѧÔÓÖ¾£¬2014£¬30(16):2675-2677
(4)±«Î°£¬ÓÚÏþ»Ô£¬ÍòСƽ. TrkBÐźÅתµ¼Í¨Â·ÔÚÖ×ÁöÖеÄ×÷ÓÃ.ÉϺ£½»Í¨´óѧѧ±¨£¨Ò½Ñ§°æ£©, 32(12):1652-1655,2012.
(5)Íõµ¤µ¤£¬Õ¿Àö£¬ÓÚÏþ»Ô*. Éñ¾­ÓªÑøÀÒ°±ËἤøÊÜÌåTrkBÔÚ×Ó¹¬ÄÚĤÒìλ֢»¼ÕßÔÚλÓëÒìλÄÚĤ×éÖ¯Öеıí´ï.Öйúҽʦ½øÐÞÔÓÖ¾, 32(18): 4 7,2009. (IF:3.869)
(6)Yu X, Liu L, Cai B, He Y, Wan X. Suppression of anoikis by the neurotrophic receptor TrkB in human ovarian cancer. Cancer Sci, 99 (3):543-552,2008.(IF:3.869)
(7)ÓÚÏþ»Ô£¬²Ì±ó£¬Ñîܲϼ£¬ÑÏÇߣ¬ÍòСƽ. ÀÒ°±ËἤøÊÜÌåBÔÚÂѳ²ÉÏƤÐÔ°©Öеıí´ï¼°ÆäÒâÒå.Öйú°©Ö¢ÔÓÖ¾, 18 (6):405-409,2008.